Valuation — not yet established
No valuation for Pivot Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($622.6M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Pivot Bio
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2021 | Later Stage VC | $434.5M | ▮ | ▮ |
| Jan 2020 | Later Stage VC | $100.0M | ▮ | ▮ |
| Sep 2018 | Later Stage VC | $71.3M | ▮ | ▮ |
| Jan 2016 | Early Stage VC | $16.0M | ▮ | ▮ |
| Oct 2014 | Seed Round | $750K | ▮ | ▮ |
How Pivot Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Pivot Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Pivot Bio raised?
- Pivot Bio has raised $622.6M in total funding across 5 recorded rounds.
- When did Pivot Bio last raise?
- Pivot Bio last raised in Jun 2021 (Later Stage VC), raising $434.5M.